Predictive Value of Molecular Subtypes in Premenopausal Women with Hormone Receptor–positive Early Breast Cancer: Results from the ABCSG Trial 5
Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna), Martin Filipits(University of Vienna), Richard Greil(Paracelsus Medical University), Sigurd Lax(Graz University Hospital), Wolfgang Hulla(Fachhochschule Wiener Neustadt), Margaretha Rudas(Comprehensive Cancer Center Vienna), W. Kwasny(State Hospital), Christian F. Singer(Comprehensive Cancer Center Vienna), Marija Balić(University of Pittsburgh), Michael Gnant(Austrian Breast & Colorectal Cancer Study Group)
Cited by 7
Related Papers
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Breast cancer
|The Lancet|2016|2.3k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k